147 related articles for article (PubMed ID: 34249328)
1. Impact of national valsartan recalls on Veterans' outcomes.
Morizio PL; Britnell SR; Ottman AA
Ther Adv Drug Saf; 2021; 12():20420986211016173. PubMed ID: 34249328
[TBL] [Abstract][Full Text] [Related]
2. An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan.
Mancia G; Korlipara K; van Rossum P; Villa G; Silvert B
Blood Press Monit; 2002 Apr; 7(2):135-42. PubMed ID: 12048432
[TBL] [Abstract][Full Text] [Related]
3. A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization - results from IQVIA™ Disease Analyzer Germany.
Hedenmalm K; Quinten C; Kurz X; Bradley M; Lee H; Eworuke E
Eur J Clin Pharmacol; 2023 Jun; 79(6):849-858. PubMed ID: 37095262
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin receptor blockade on central aortic systolic blood pressure in hypertensive Asians measured using radial tonometry: an open prospective cohort study.
Teong HH; Chin AM; Sule AA; Tay JC
Singapore Med J; 2016 Jul; 57(7):384-9. PubMed ID: 26875683
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
[TBL] [Abstract][Full Text] [Related]
6. Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach.
Nixon RM; Müller E; Lowy A; Falvey H
Int J Clin Pract; 2009 May; 63(5):766-75. PubMed ID: 19392925
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan.
Weycker D; Keskinaslan A; Levy DG; Edelsberg J; Kartashov A; Oster G
Blood Press Suppl; 2008 Dec; 2():5-12. PubMed ID: 19205091
[TBL] [Abstract][Full Text] [Related]
8. Neoplasm Reports in Food and Drug Administration Adverse Event Reporting System Following Angiotensin Receptor Blocker Recalls.
Cohen Sedgh R; Moon J; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2021 Aug; 14(8):e007476. PubMed ID: 34380327
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical modeling of blood pressure determinants and outcomes following valsartan treatment in hypertensive patients with known comorbidities: pooled analysis of six prospective real-world studies including 11,999 patients.
Alkhatib N; Sun D; Denhaerynck K; Hamarneh D; Van Camp Y; Villa L; Brié H; Vancayzeele S; MacDonald K; Abraham I
Curr Med Res Opin; 2021 Jan; 37(1):1-8. PubMed ID: 33206572
[TBL] [Abstract][Full Text] [Related]
10. Comparison of valsartan and amlodipine on ambulatory blood pressure variability in hypertensive patients.
Eguchi K; Imaizumi Y; Kaihara T; Hoshide S; Kario K
Clin Exp Hypertens; 2016; 38(8):721-724. PubMed ID: 27936949
[TBL] [Abstract][Full Text] [Related]
11. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
12. Automated office and home phone-transmitted blood pressure recordings in uncontrolled hypertension treated with valsartan and hydrochlorothiazide.
Girerd X; Denolle T; Yau C; Fiquet B; Brunel P; Moulin B; Herpin D
Blood Press Suppl; 2004 Dec; 2():18-24. PubMed ID: 15631279
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
14. Effects of the angiotensin receptor blocker Valsartan (Valsacor®) on arterial pressure, indices of myocardial diastolic function and global longitudinal strain in patients with uncontrolled arterial hypertension.
Vitlyanova K; Naidenov S; Runev N; Manov E; Shabani R; Rangelov Y; Koshtikova K; Donova T
Vnitr Lek; 2013 Dec; 59(12):1124-8. PubMed ID: 24466609
[TBL] [Abstract][Full Text] [Related]
15. 24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension.
Lee HY; Kim CH; Song JK; Chae SC; Jeong MH; Kim DS; Oh BH
Korean J Intern Med; 2017 Nov; 32(6):1025-1036. PubMed ID: 29032666
[TBL] [Abstract][Full Text] [Related]
16. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
[TBL] [Abstract][Full Text] [Related]
17. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL; Ekhlas A; Nguyen JM; Moranne O
Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
[TBL] [Abstract][Full Text] [Related]
18. Changes in ophthalmic artery Doppler during acute blood-pressure control in hypertensive pregnant women.
Lau KG; Baloi M; Dumitrascu-Biris D; Nicolaides KH; Kametas NA
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):185-191. PubMed ID: 34358385
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy.
Sinkiewicz W; Glazer RD; Kavoliuniene A; Miglinas M; Prak H; Wernsing M; Yen J
Curr Med Res Opin; 2009 Feb; 25(2):315-24. PubMed ID: 19192976
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
